A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age

Clinical trial NCT06602024 · COMPLETED

Trial details

NCT number: NCT06602024
Sponsor: ModernaTX, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Seasonal Influenza

Start date: 2024-09-16
Primary completion: 2025-08-21
Enrollment: 40817

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.